Hu Yu

[Expert Profile] Hu Yu, Chief Physician, Professor, Doctoral Supervisor, is an authoritative expert in thrombosis and hemostasis diseases in China, working in the Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. He has long been dedicated to clinical diagnosis, treatment, and scientific research of difficult thrombotic and hemorrhagic hematological diseases, and is an important leading figure in hematology in China.

[Education & Career] Professor Hu Yu graduated from Tongji Medical University, completed systematic clinical training at Union Hospital, Tongji Medical College, HUST, and further studied at famous international hematology centers. He has long served as President of Union Hospital and Director of the Department of Hematology, holding important academic positions including Vice Chair of the Hematology Branch of the Chinese Medical Association. He has presided over key grants from the National Natural Science Foundation of China and the National Key R&D Program, and has accumulated profound academic achievements in the fields of thrombosis and hemostasis diseases.

[Areas of Expertise] Professor Hu specializes in the diagnosis and treatment of difficult thrombotic and hemorrhagic hematological diseases such as thrombotic thrombocytopenic purpura (TTP), disseminated intravascular coagulation (DIC), thrombophilia, and hemophilia. He has extensive experience in precise diagnosis of coagulation disorders, plasma exchange, and standardized application of novel anticoagulant/hemostatic drugs. He excels at managing difficult critical cases of "unexplained thrombosis or bleeding," helping numerous thrombotic/hemorrhagic disease patients identify causes, control conditions, and avoid fatal complications.

[Academic Achievements & Industry Contributions] Professor Hu has led a series of clinical and basic studies on thrombosis and hemostasis diseases, systematically exploring the pathogenesis and diagnosis/treatment strategies of TTP, DIC, and related conditions, with findings published in authoritative domestic and international journals. He has led the development of Chinese thrombosis and hemostasis disease-related diagnosis and treatment guidelines and expert consensus statements, actively promoted the standardized construction of venous thromboembolism (VTE) prevention and treatment systems in hospitals, and led multi-center collaborative research, making important contributions to improving the diagnosis and treatment level of thrombotic/hemorrhagic diseases and ensuring patient safety in China.

[Clinical Practice & Outstanding Contributions] For decades on the clinical front lines, Professor Hu has treated tens of thousands of patients with difficult thrombotic/hemorrhagic hematological diseases, successfully managing numerous critical TTP and DIC patients. With noble medical ethics and exceptional technical skill, he is deeply trusted by patients and respected by peers alike. He has received multiple national and industry honors, trained a large number of hematology professionals, and is an outstanding expert in the fields of thrombosis and hemostasis diseases in China.

[Honors & Reputation] Professor Hu Yu serves as President of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology and Vice Chair of the Hematology Branch of the Chinese Medical Association, among other academic positions. He has presided over national-level major projects including the National Key R&D Program, and is an authoritative expert in the field of hematology in China. He has profound expertise in the diagnosis and treatment of difficult thrombotic/hemorrhagic hematological diseases and hematologic malignancies. He has led standardized diagnosis and treatment research on hemorrhagic diseases such as disseminated intravascular coagulation (DIC), brought China's thrombosis and hemostasis field to an internationally advanced level, and has research findings published in international authoritative journals, receiving multiple science and technology awards. For decades on the clinical front lines, he has helped numerous difficult hematology patients receive clear diagnoses and standardized treatment, and is deeply trusted by patients and respected by peers alike.